All In MedTech

FDA Clearance Tracker · P020014-S019

ESSURE CONTRACEPTIVE TUBAL OCCLUSION DEVICE AND DELIVERY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 8, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 8, 2008

Approved

Time to decision

100 days

Received Jun 30, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P020014-S019
Device name
ESSURE CONTRACEPTIVE TUBAL OCCLUSION DEVICE AND DELIVERY SYSTEM
Applicant location
Berlin
Received
Jun 30, 2008
Decided
Oct 8, 2008
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P020014

Device type

Device class
Class III
Regulation
21 CFR 884.5380

Every decision under product code HHS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A CONTRACT STERILIZATION SITE LOCATED AT STERIGENICS US, INC., SANTA TERESA, NEW MEXICO.

Source documents

Other decisions for Bayer Pharma AG

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.